BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

PLoS By Category | Recent PLoS Articles
Immunology - Ophthalmology - Physiology

Small Heat Shock Protein aA-Crystallin Prevents Photoreceptor Degeneration in Experimental Autoimmune Uveitis
Published: Friday, March 30, 2012
Author: Narsing A. Rao et al.

by Narsing A. Rao, Sindhu Saraswathy, Geeta Pararajasegaram, Suraj P. Bhat

The small heat shock protein, aA-crystallin null (aA-/-) mice are known to be more prone to retinal degeneration than the wild type mice in Experimental Autoimmune Uveoretinitis (EAU). In this report we demonstrate that intravenous administration of aA preserves retinal architecture and prevents photoreceptor damage in EAU. Interestingly, only aA and not aB-crystallin (aB), a closely related small heat shock protein works, pointing to molecular specificity in the observed retinal protection. The possible involvement of aA in retinal protection through immune modulation is corroborated by adaptive transfer experiments, (employing aA-/- and wild type mice with EAU as donors and Rag2-/- as the recipient mice), which indicate that aA protects against the autoimmune challenge by modulating the systemic B and T cell immunity. We show that aA administration causes marked reduction in Th1 cytokines (TNF-a, IL-12 and IFN-?), both in the retina and in the spleen; notably, IL-17 was only reduced in the retina suggesting local intervention. Importantly, expression of Toll-like receptors and their associated adaptors is also inhibited suggesting that aA protection, against photoreceptor loss in EAU, is associated with systemic suppression of both the adaptive and innate immune responses.
  More...

 

//-->